WHO ICTRP trial
Impact of GLUBLOCâ?¢ on healthy individuals
CTRI/2023/05/052654 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/05/052654 |
|---|---|
| Public title | Impact of GLUBLOCâ?¢ on healthy individuals |
| Scientific title | Impact of GLUBLOCâ?¢ on postprandial blood glucose and insulin levels in healthy individuals post high carb meal intake |
| Primary sponsor | My Pura Vida Wellness Private Limited (Puravida) |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Interventions | Intervention1: GLUBLOC Morus alba and Malus domestica: 500mg/ Day Total Duration 2 days (Day 1 and Day 5) Control Intervention1: Placebo Vitamin C: 500mg/day Total Duration 2 days (Day 1 and Day 5) |
| Registration date | May 15, 2023 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: